Annual report pursuant to Section 13 and 15(d)

Consolidated Statement of Changes in Stockholders' (Deficit) Equity

v3.21.2
Consolidated Statement of Changes in Stockholders' (Deficit) Equity - USD ($)
shares in Thousands, $ in Thousands
Preferred Stock [Member]
Common Stock
Registered Direct Offering [Member]
Common Stock
Public Warrant Tender Offering [Member]
Common Stock
Private Warrant Exchange [Member]
Common Stock
Private Placement [Member]
Common Stock
Treasury Stock
Additional Paid-in Capital [Member]
Registered Direct Offering [Member]
Additional Paid-in Capital [Member]
Public Warrant Tender Offering [Member]
Additional Paid-in Capital [Member]
Private Warrant Exchange [Member]
Additional Paid-in Capital [Member]
Private Placement [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit
Registered Direct Offering [Member]
Public Warrant Tender Offering [Member]
Private Warrant Exchange [Member]
Private Placement [Member]
Total
Beginning balance at May. 31, 2018           $ 217           $ 159,765 $ (173,139)         $ (13,158)
Beginning balance, shares at May. 31, 2018 92         216,882 159                      
Acquisition of ProstaGene LLC, value           $ 19           11,539           11,558
Shares issued in acquisition           18,658                        
Issuance of stock payment shares, value           $ 8           (8)           0
Issuance of stock payment shares, shares           8,342                        
Issuance of stock for convertible note repayment, value           $ 4           1,451           1,455
Issuance of stock for convertible note, shares           3,756                        
Stock issued via offering, tender or placement, value   $ 24   $ 11 $ 47     $ 11,791   $ 2,955 $ 23,441 3,084   $ 11,815   $ 2,966 $ 23,488 3,084
Stock issued via offering, tender or placement, shares 3 23,630   11,312 46,975                       47,000  
Offering costs, stock and warrants               (1,130)   (267) (2,697)     (1,130)   (267) $ (2,697)  
Issuance costs related to debt offering                       261           261
Debt discount costs related to debt offering                       3,059           3,059
Beneficial conversion feature on note payable and relative fair value associated with warrants                       3,535           3,535
Inducement interest expense                       196           196
Dividends accrued on preferred stock                         (37)         (37)
Legal fees in connection with equity offerings                       (243)           (243)
Stock-based compensation                       3,388           3,388
Stock issued for services, value                                   8
Net loss                         (56,187)         (56,187)
Ending balance at May. 31, 2019           $ 330           220,120 (229,363)         (8,913)
Ending balance, shares at May. 31, 2019 95         329,555 159                      
Issuance of stock for convertible note repayment, value           $ 23           10,799           10,822
Issuance of stock for convertible note, shares           22,967                        
Stock issued via offering, tender or placement, value   $ 39 $ 45 $ 20       12,627 $ 11,855 6,001   13,409   12,666 $ 11,900 6,021   13,409
Stock issued via offering, tender or placement, shares 14 38,856 45,376 20,529                            
Offering costs, stock and warrants               $ (378) (1,059) (197)   (437)   $ (378) (1,059) (197)   (437)
SHARES PLACEHOLDER           8,232                        
Inducement interest expense                 $ 2,713 5,191         $ 2,713 5,191    
Dividends accrued on preferred stock                         (945)         (945)
Legal fees in connection with equity offerings                       (16)           (16)
Stock-based compensation                       6,548           6,548
Note conversion and extension fees           $ 8           3,891           3,899
Warrant exercises, value           $ 42           20,458           20,500
Warrant exercises, shares           42,024                        
Relative fair market value associated with warrants exercised                       11,949           11,949
Exercise of option to repurchase common stock, value                       (8)           (8)
Stock issued for services, value           $ 3           (3)           3
Stock issued for services, shares           2,620                        
Stock issued for incentive compensation and tendered for income tax                       154           154
Stock issued for incentive compensation and tendered for income tax , shares           380 127                      
Stock option exercises, value           $ 9           5,594           5,603
Stock option exercises, shares           8,723                        
Stock issued in legal settlement, value                       22,500           22,500
Net loss                         (124,403)         (124,403)
Ending balance at May. 31, 2020           $ 519           351,711 (354,711)         $ (2,481)
Ending balance, shares at May. 31, 2020 109         519,262 286                      
Issuance of stock payment shares, shares                                   8,300
Issuance of stock for convertible note repayment, value           $ 24           77,679           $ 77,703
Issuance of stock for convertible note, shares           24,154                        
Stock issued via offering, tender or placement, value       $ 37 $ 1         17,519 $ 999         17,556 $ 1,000  
Stock issued via offering, tender or placement, shares       37,054 667                          
Offering costs, stock and warrants                   $ (495)           $ (495)    
Inducement interest expense                       11,366           11,366
Dividends accrued on preferred stock                         (1,909)         (1,909)
Stock-based compensation                       8,822           8,822
Warrant exercises, value           $ 38           19,390           $ 19,428
Warrant exercises, shares           37,941                       27,300
Stock issued for incentive compensation and tendered for income tax                       828           $ 828
Stock issued for incentive compensation and tendered for income tax , shares           323 157                      
Stock option exercises, value           $ 3           1,835           $ 1,838
Stock option exercises, shares           2,591                       2,600
Stock issued in legal settlement, value           $ 4           (4)            
Stock issued in legal settlement, shares           4,000                        
Conversion of Series B preferred stock to common stock, shares (13)         131                        
Net loss                         (154,674)         $ (154,674)
Ending balance at May. 31, 2021           $ 626           $ 489,650 $ (511,294)         $ (21,018)
Ending balance, shares at May. 31, 2021 96         626,123 443